Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients?
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
A. Ismaila (Cary, United States of America). Single inhaler triple therapy in patients with advanced COPD: healthcare resource utilisation and cost data from the FULFIL study. 2791

Member's Comments

No comment yet.

Related content which might interest you: Impact of once-daily single inhaler triple therapy on healthcare resource utilization and associated costs in COPD patients in Spain Source: International Congress 2018 – COPD, asthma and tuberculosis: benefits related to therapy costs Year: 2018 Late Breaking Abstract - IMPACT study — single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: healthcare resource utilization and costs — UK Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018 Budesonide/formoterol in a single inhaler improves health status in patients with COPD without increasing healthcare costs Source: Eur Respir J 2003; 22: Suppl. 45, 50s Year: 2003 Cost impact of time to initiation of triple therapy in COPD patients in Japan: A retrospective analysis of healthcare claims data Source: International Congress 2017 – Does economisation of medicine transfer into benefits for patients? Year: 2017 Step-down of non-indicated triple therapy in COPD using routine primary care data: A regional pilot study Source: International Congress 2018 – Primary care management of COPD Year: 2018 Single inhaler triple therapy in patients with advanced COPD (FULFIL): exacerbation/pneumonia composite outcomes Source: International Congress 2017 – COPD management Year: 2017 Dispensed asthma therapy and medical resource utilisation in asthma patients: results from the L777 observational study Source: Annual Congress 2009 - Epidemiology of asthma Year: 2009 COPD guides and inhaled corticosteroids. Is there an adequate use in primary care? Source: International Congress 2016 – Targeting care, pulmonary rehabilitation, management, and self-management of COPD exacerbations in primary care Year: 2016 Efficacy of comprehensive education program including inhaler training and disease management on COPD Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Effects of educational intervention using respiratory inhaler by advanced practice nurse in teaching COPD patients: an interim analysis Source: International Congress 2019 – Inhalers: adherence and preference Year: 2019 Single inhaler triple therapy in advanced COPD patients: prior medication and disease severity FULFIL subanalyses Source: International Congress 2017 – COPD management Year: 2017 Reducing inappropriate high dose ICS prescribing for COPD in primary care using respiratory integrated care virtual clinics Source: International Congress 2015 – Management of COPD and other respiratory diseases in primary care Year: 2015 Clinically important deterioration in advanced COPD patients using single inhaler triple therapy: results from the FULFIL study Source: International Congress 2017 – Management of COPD Year: 2017 Characteristics of new users of single and multiple-inhaler triple therapy for COPD in primary care in England Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Reducing the use of inhaled corticosteroids in mild COPD patients treated in primary care by a training program in national guidelines and using a portable device to measure pulmonary function Source: Eur Respir J 2005; 26: Suppl. 49, 294s Year: 2005 IMPACT: Healthcare resource use data and associated costs for single-inhaler triple therapy versus dual therapies in Spain Source: Virtual Congress 2021 – Difficult decisions on expected outcomes: availability of hospital resources and improvement of treatment adherence Year: 2021 Single inhaler triple therapy in patients with COPD: patient-reported dyspnoea and health status from the IMPACT Trial Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018 The patient’s role in the choice of new inhaler devices and dosing regimens for asthma and COPD: A preference study Source: International Congress 2016 – Kaleidoscope of respiratory nursing Year: 2016 Cost consequences of tiotropium plus existing therapy versus existing therapy alone following one year of treatment in patients with COPD Source: Eur Respir J 2001; 18: Suppl. 33, 5s Year: 2001